By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

3-V Biosciences 

1050 Hamilton Court

Menlo Park  California  94025  U.S.A.
Phone: 650-561-8600 Fax: N/A


SEARCH JOBS



Segment
Pharmaceuticals





Company News
3-V Biosciences Commences Patient Dosing In Phase 1 Clinical Study Of FASN Inhibitor TVB-2640 In Patients With Advanced Solid Tumors 12/4/2013 10:59:24 AM
3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the American Association for Cancer Research-National Cancer Institute-EORTC International Conference on Molecular Targets and Cancer Therapeutics 10/21/2013 2:29:21 PM
3-V Biosciences Nabs $20 Million Series C 6/21/2013 7:06:02 AM
3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012 11/12/2012 10:15:53 AM
3-V Biosciences to Present Data on HCV Product Candidates at the American Association for Study of Liver Diseases Annual Meeting 2012 10/1/2012 11:09:11 AM
3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference 7/10/2012 9:50:37 AM
3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology 6/29/2012 10:39:00 AM
3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer 8/15/2011 11:31:16 AM
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer 2/10/2011 7:24:03 AM
3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer 9/30/2010 8:03:09 AM
12
//-->